Kala Bio (KALA) Cash & Current Investments (2016 - 2026)
Kala Bio (KALA) reported Cash & Current Investments of $7.23 million for Q2 2026, down 77.4% from $31.94 million a year earlier and down 17.5% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Cash & Current Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Kala Bio posted Cash & Current Investments of $7.56 million, down 85.2% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of -44.2% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $51.18 million in FY2024 (+0.6%), $50.9 million in FY2023 (+61.1%), $31.59 million in FY2022 (-63.3%) and $86.14 million in FY2021 (-38.5%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments in data going back to Q2 2016.
- Year over year, Cash & Current Investments has now declined in each of the last six quarters, with an average decline of 45.6% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q2 2023 (growth of 61.8%); the low point was Q4 2025 (a decline of 85.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.76 million (Q1 2026), $7.56 million (Q4 2025) and $21.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,243.39 Bn | 1,217.00 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 667.00 Bn | 586.86 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 513.50 Bn | 481.51 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.97 Bn | 325.91 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 314.03 Bn | 287.27 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 291.59 Bn | 265.49 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 247.24 Bn | 198.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.09 Bn | 183.20 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 166.41 Bn | 113.77 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Kala Bio | 2.52 Mn | -42.12 Mn | - | 7.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.23 Mn |
| Mar 31, 2026 | 8.76 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | 21.10 Mn |
| Jun 30, 2025 | 31.94 Mn |
| Mar 31, 2025 | 42.22 Mn |
| Dec 31, 2024 | 51.18 Mn |
| Sep 30, 2024 | 49.20 Mn |
| Jun 30, 2024 | 54.20 Mn |
| Mar 31, 2024 | 48.48 Mn |
| Dec 31, 2023 | 50.90 Mn |
| Sep 30, 2023 | 56.06 Mn |
| Jun 30, 2023 | 58.55 Mn |
| Mar 31, 2023 | 63.64 Mn |
| Dec 31, 2022 | 31.59 Mn |
| Sep 30, 2022 | 52.39 Mn |
| Jun 30, 2022 | 36.18 Mn |
| Mar 31, 2022 | 66.14 Mn |
| Dec 31, 2021 | 86.14 Mn |
| Sep 30, 2021 | 106.13 Mn |
API Access
Kala Bio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();